April 16, 2020

Company Agrees to Pay $43 Million to Resolve Investigation Concerning Misbranded Endoscopes

Pentax Medical Company will pay $43 million to resolve criminal charges based on the company’s shipment of four types of endoscopes for 18 months without FDA-cleared instructions for use, as well as the company’s failure to file timely reports of two infections associated with endoscopes it supplied.